Disrupting the disruptors: What does Uber's London ban mean for investors?

The concerns that come with investing in innovative companies

Anna Fedorova
clock • 2 min read

London was shaken up last week by news transport disruptor Uber was set to lose its licence to operate in the city from 30 September, due to a number of failings.

The city was divided by the news - some were in full support of the Mayor of London Sadiq Khan and Transport for London (TfL) for going ahead with the ban - but many were dismayed at the impact on their daily lives. After all, "uber" has become the equivalent of "taking a taxi" in Londoners' vocabularies.  But aside from Uber's specific maladies, there are bigger picture implications as to what happens to market disruptors such as Uber, Netflix or Airbnb when they become big enough to draw the attention of the authorities and face crackdowns on the way their businesses are operating. ...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot